Reuters: Regulatory News: McKesson in $190 mln False Claims Act settlement

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

McKesson in $190 mln False Claims Act settlement Apr 26th 2012, 14:20 April 26 | Thu Apr 26, 2012 10:20am EDT April 26 (Reuters) - McKesson Corp, a large U.S. drug wholesaler, has agreed to pay more than $190 million to settle claims that it violated the federal False Claims Act by reporting inflated pricing information for many prescription drugs, causing Medicaid to overpay for those drugs. The settlement was announced Thursday by U.S. Attorney Paul Fishman in New Jersey. McKesson did not admit liability in agreeing to settle. According to the government, McKesson reported inflated pricing data to First DataBank, a publisher of drug prices that most state Medicaid programs use to set payment rates for pharmaceutical products. Fishman said state governments may negotiate separately with McKesson to resolve claims based on their individual shares of the Medicaid overpayments.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions